Refresh

Tatva Chintan Pharma Chem Ltd. - Research Center

543321 TATVA Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

378.68 403.04 427.81 291.19 253.84
Expenses

Material consumed

185.73 239.15 209.49 151.79 135.80

Manufacturing expenses

34.78 23.61 22.62 9.92 8.96

Personnel expenses

54.76 38.60 30.81 24.13 20.53

Selling expenses

- - - - -

Adminstrative expenses

36.54 47.01 59.12 40.16 36.16

Expenses capitalised

- - - - -

Cost of sales

311.81 348.37 322.04 226.00 201.45

Operating profit

66.87 54.68 105.77 65.19 52.39

Other recurring income

7.51 5.68 10.51 5.10 0.56

Adjusted PBDIT

74.37 60.36 116.28 70.29 52.95

Financial expenses

6.51 8.38 4.83 4.21 3.94

Depreciation

25.60 9.55 8.18 6.73 4.79

Other write offs

- - - - -

Adjusted PBT

42.27 42.42 103.27 59.35 44.22

Tax charges

12.92 -1.63 7.28 7.99 9.25

Adjusted PAT

29.35 44.05 95.99 51.36 34.96

Non recurring items

- -3.59 - - -

Other non cash adjustments

- - - - -

Reported net profit

29.35 40.47 95.99 51.36 34.96

Earnigs before appropriation

303.26 278.34 237.88 157.97 106.61

Equity dividend

4.68 4.43 - 4.02 -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

298.58 273.91 237.88 153.95 106.61
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com